Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIB Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01861938
What this trial is testing

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Who this might be right for
High Risk HLA-A2+ MelanomaMetastatic Disease
Hadassah Medical Organization
Early research (Phase 1)Active Not RecruitingNCT06551064
What this trial is testing

Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients

Who this might be right for
Melanoma, Stage IIMelanoma Stage III
Formycon AG 96
Testing effectiveness (Phase 2)Study completedNCT02126579
What this trial is testing

Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists

Who this might be right for
MelanomaMetastatic MelanomaMucosal Melanoma
Craig L Slingluff, Jr 50
Not applicableActive Not RecruitingNCT07259304
What this trial is testing

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+97 more
University of Southern California 118
Testing effectiveness (Phase 2)Looking for participantsNCT07349303
What this trial is testing

Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma

Who this might be right for
Melanoma (Skin Cancer)
Vastra Gotaland Region 30
Not applicableStudy completedNCT00897546
What this trial is testing

Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 1,716
Not applicableUnknownNCT00897481
What this trial is testing

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

Who this might be right for
Melanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 1,000
Early research (Phase 1)Looking for participantsNCT07475572
What this trial is testing

Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

Who this might be right for
Melanoma
Alvotech Swiss AG 120
Testing effectiveness (Phase 2)Study completedNCT03405155
What this trial is testing

Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 26
Testing effectiveness (Phase 2)Study completedNCT00031733
What this trial is testing

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 60
Early research (Phase 1)Study completedNCT00398073
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center 35
Large-scale testing (Phase 3)Ended earlyNCT01546571
What this trial is testing

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Who this might be right for
Melanoma
Polynoma LLC 504
Not applicableLooking for participantsNCT03116412
What this trial is testing

Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

Who this might be right for
Malignant Melanoma
Uppsala University 1,300
Early research (Phase 1)Study completedNCT01456104
What this trial is testing

Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 9
Very early researchStudy completedNCT00580060
What this trial is testing

Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00938223
What this trial is testing

Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 51
Early research (Phase 1)Study completedNCT00142454
What this trial is testing

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

Who this might be right for
Malignant Melanoma
Ludwig Institute for Cancer Research 9
Not applicableUnknownNCT00445783
What this trial is testing

Study of Families With Melanoma

Who this might be right for
Melanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 3,700
Not applicableUnknownNCT00450593
What this trial is testing

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

Who this might be right for
Hereditary Multiple MelanomaMelanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 5,000
Early research (Phase 1)Active Not RecruitingNCT04875728
What this trial is testing

The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma

Who this might be right for
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8Clinical Stage IB Cutaneous Melanoma AJCC v8+11 more
M.D. Anderson Cancer Center 20
Next Page